A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany
Weiguang Xue,1 Adam Lloyd,1 Edel Falla,1 Claudia Roeder,2 Rudiger Papsch,2 Klaus Bühler3,41IQVIA, Real-World Evidence, London, UK; 2Merck KGaA, Frankfurt, Germany; 3Centre for Gynecology Endocrinology & Reproductive Medicine Kinderwunsch-Zentrum Stuttgart, Stuttgart, Germany; 4Department of Gyn...
Saved in:
Main Authors: | Xue W (Author), Lloyd A (Author), Falla E (Author), Roeder C (Author), Papsch R (Author), Bühler K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
by: Gizzo S, et al.
Published: (2016) -
A letter to editor - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France."
by: Juan-Enrique Schwarze, et al.
Published: (2024) -
An observational study «FOLLITROPIN» comparing the efficacy of follitropin alpha biosimilar: the real-world data
by: D. P. Kamilova, et al.
Published: (2021) -
Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France
by: Matthieu Lehmann, et al.
Published: (2024) -
THE NOVEL BIOSIMILAR OF FOLLITROPIN ALPHA TO BE MANUFACTURED IN RUSSIA STARTING FROM 2017
by: I. I. Vorobiev, et al.
Published: (2017)